Who
Nachum Shamir
Director
Company insider
Files Form 4 as: Director, Stereotaxis; Director, MediWound; Director, STRATA Skin Sciences; Director, IsoPlexis; President & CEO, Luminex; Director, Cogentix Medical Inc /de/.
In numbers
- Trades disclosed
- 91
- Buys
- 9
- Sells
- 6
- Bought
- $773K
- Sold
- $17.4M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 14 Oct 2014
- Last trade
- 1 Jul 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 1 Jul 2026 | STXS StereotaxisMedical Devices | SEC FORM 4 Code A | —43,103 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | STXS StereotaxisMedical Devices | SEC FORM 4 Code A | —43,103 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | MDWD MediWoundBiotechnology | SEC FORM 4 Bought | $2,446175 at $13.98 | filing |
| 3 Jun 2026filed 4 Jun 2026 | MDWD MediWoundBiotechnology | SEC FORM 4 Bought | $82K5,825 at $14.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | MDWD MediWoundBiotechnology | SEC FORM 4 Bought | $2,447175 at $13.98 | filing |
| 3 Jun 2026filed 4 Jun 2026 | MDWD MediWoundBiotechnology | SEC FORM 4 Bought | $82K5,825 at $14.00 | filing |
| 2 Jan 2026filed 2 Jan 2026 | STXS StereotaxisMedical Devices | SEC FORM 4 Code A | —46,948 at $0.00 | filing |
| 2 Jan 2026filed 2 Jan 2026 | STXS StereotaxisMedical Devices | SEC FORM 4 Code A | —46,948 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | STXS StereotaxisMedical Devices | SEC FORM 4 Code A | —43,668 at $0.00 | filing |
| 2 Jan 2025filed 2 Jan 2025 | STXS StereotaxisMedical Devices | SEC FORM 4 Code A | —45,608 at $0.00 | filing |
| 5 Jul 2023filed 7 Jul 2023 | STRATA Skin Sciences | SEC FORM 4 Code A | $40K38,835 at $1.03 | filing |
| 21 Mar 2023filed 21 Mar 2023 | IsoPlexisoption or derivative | SEC FORM 4 Code D | —196,842 | filing |
| 21 Mar 2023filed 21 Mar 2023 | IsoPlexis | SEC FORM 4 Code D | —50,253 | filing |
| 31 Aug 2022filed 1 Sep 2022 | IsoPlexis | SEC FORM 4 Bought | $78K40,000 at $1.94 | filing |
| 30 Aug 2022filed 1 Sep 2022 | IsoPlexis | SEC FORM 4 Bought | $19K10,253 at $1.89 | filing |
| 22 Aug 2022filed 24 Aug 2022 | IsoPlexisoption or derivative | SEC FORM 4 Code A | —196,842 at $0.00 | filing |
| 1 Jul 2022filed 5 Jul 2022 | STRATA Skin Sciences | SEC FORM 4 Code A | $40K43,244 at $0.93 | filing |
| 8 Sep 2021filed 9 Sep 2021 | STRATA Skin Sciences | SEC FORM 4 Bought | $2,2361,542 at $1.45 | filing |
| 8 Sep 2021filed 9 Sep 2021 | STRATA Skin Sciences | SEC FORM 4 Bought | $3,4782,382 at $1.46 | filing |
| 8 Sep 2021filed 9 Sep 2021 | STRATA Skin Sciences | SEC FORM 4 Bought | $147100 at $1.47 | filing |
News
MediWound Ltd. (NASDAQ:MDWD) Stock Has Consensus Target Price of $33.00 According to BrokeragesMDWD · dailypolitical.com · 18 Oct 2026Head-To-Head Survey: Taysha Gene Therapies (NASDAQ:TSHA) vs. MediWound (NASDAQ:MDWD)MDWD · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Nachum Shamir; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.